Fetal calf sera can distort cell-based luminescent proteasome assays through heat-resistant chymotrypsin-like activity |
| |
Authors: | Susan Dettmer,Dirk Theile,Anja Seckinger,Jü rgen Burhenne,Johanna Weiss |
| |
Affiliation: | 1. Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, D-69120 Heidelberg, Germany;2. Department of Internal Medicine V, Oncology, Hematology, and Rheumatology, Heidelberg University Hospital, D-69120 Heidelberg, Germany |
| |
Abstract: | ![]() Luminescence-based proteasome activity assays use specific substrates that are supposed to be cleaved by cellular proteasome activity leading to luciferase substrates. Usually, control wells containing cell culture medium supplemented with antibiotics and fetal calf serum are used as background. Using the Proteasome-Glo chymotrypsin-like cell-based assay from Promega, we show here that fetal calf sera from different manufacturers contain heat-resistant, bortezomib-inhibitable, chymotrypsin-like activities that can interfere with proteasome activity assays. These data strongly recommend the use of pure phosphate-buffered saline (PBS) or serum-free medium during proteasome activity assays to diminish background luminescence and, thus, to obtain reliable results. |
| |
Keywords: | Proteasome activity Proteasome-Glo chymotrypsin-like cell-based assays Fetal calf serum Heat resistance Bortezomib Carfilzomib |
本文献已被 ScienceDirect 等数据库收录! |
|